Outcome of relapsed/refractory AML patients with IDH1R132 mutations in real life before the era of IDH1 inhibitors.
Leuk Lymphoma
; 61(2): 473-476, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31566052
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Isocitrate Dehydrogenase
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Type:
Article
Affiliation country:
France